Newsroom
Zhifei Longcom Recombinant COVID-19 Vaccine Receives Marketing Approva...
Zhifei Longcom Recombinant COVID-19 Vaccine Receives Marketing Approval in Kenya
2022-12-23
On December 22, the Company's Recombinant COVID-19 Vaccine (CHO Cell) was approved for marketing by the Pharmacy and Poisons Board (PPB) of...
Zhifei Longcom Passes EU QP Audit, An Acceleration in Zhifei’s Intern...
Zhifei Longcom Passes EU QP Audit, An Acceleration in Zhifei’s International Strategic Layout
2022-11-09
On November 8, 2022, the Recombinant COVID-19 Vaccine (CHO Cell) and the Recombinant COVID-19 Omicron-Delta Variant Vaccine (CHO Cell) of An...
Zhifei’s Second-generation Recombinant COVID-19 Vaccine Starts Intern...
Zhifei’s Second-generation Recombinant COVID-19 Vaccine Starts International Clinical Trial
2022-11-09
Source: Xinhua News Agency The launch ceremony of the international clinical trial of the Recombinant COVID-19 Omicron-Delta Variant Vaccin...